Donghui Lou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Donghui Lou has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Jay J. Shen
Department of Healthcare Administration and Policy, School of Public Health, University of Nevada, Las Vegas, Nevada
2 shared publications Betty Burston
Department of Health Administration, School of Public Health, University of Nevada, Las Vegas, NV, USA
1 shared publication- Bo Liu
Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia
1 shared publication Christopher Cochran
Department of Health Administration, School of Public Health, University of Nevada, Las Vegas, NV, USA
1 shared publicationChun-Mei Qin
Department of Endocrinology, The First Hospital of Qinhuangdao, Hebei Medical University, No. 258 Wenhua Road, Qinhuangdao, 066000 Hebei Province, China
1 shared publication- Chun-Ming Ma
Department of Endocrinology, The First Hospital of Qinhuangdao, Qinhuangdao, China
1 shared publication
Latest Publications
- Open Access
- 1 August 2025
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 18, 2815-2823
Risk Factors of Developing Dysmobility Syndrome in Elderly Patients with Type 2 Diabetes Mellitus
Background: Population aging is a worldwide phenomenon, and aging-related diseases need to be given great attention. Dysmobility syndrome (DMS) was considered as a comprehensive approach to evaluate the condition of musculoskeletal system and adverse health problems in older population. Aim: There is little research data on the correlation between type 2 diabetes and DMS in the elderly. The purpose of our study is to identify the risk factors for dysmobility syndrome (DMS) in elderly patients with type 2 diabetes mellitus (T2DM). Methods: A total of 262 patients aged > 60 years who were diagnosed with T2DM at our department were included in a cross-sectional study and were divided into groups according to the development of DMS and the number of presentations, including osteoporosis, low muscle strength and mass, obesity, falls, and slow walking speed. Consequently, 128 patients with non-DMS were assigned to group A, 84 patients with to 2– 3 presentations (without falls) were assigned to group B, and 50 patients with to 4– 5 presentations (without falls) were assigned to group C. Demographic data, diabetes-related complications, and history of falls in the past year were compared to identify risk factors for developing DMS in elderly T2DM patients. Results: It showed that 50.4% of the elderly T2DM patients developed DMS, and 25.2% of them had at least one episode of falling. The average age of the patients and the occurrence of diabetic nephropathy were higher, while diastolic blood pressure and 25-(OH) vitamin D serum calcium and albumin levels were lower in group C than in group A and B(p < 0.05). The occurrence of falls was lower in group A than in the other groups (p = 0.001). Conclusion: Aging, 25 (OH) vitamin D deficiency, and accidental fall history are associated with an increased risk of DMS in elderly patients with T2DM.
- 1 August 2025
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 18, 2815-2823
Open AccessRisk Factors of Developing Dysmobility Syndrome in Elderly Patients with Type 2 Diabetes Mellitus
Background: Population aging is a worldwide phenomenon, and aging-related diseases need to be given great attention. Dysmobility syndrome (DMS) was considered as a comprehensive approach to evaluate the condition of musculoskeletal system and adverse health problems in older population. Aim: There is little research data on the correlation between type 2 diabetes and DMS in the elderly. The purpose of our study is to identify the risk factors for dysmobility syndrome (DMS) in elderly patients with type 2 diabetes mellitus (T2DM). Methods: A total of 262 patients aged > 60 years who were diagnosed with T2DM at our department were included in a cross-sectional study and were divided into groups according to the development of DMS and the number of presentations, including osteoporosis, low muscle strength and mass, obesity, falls, and slow walking speed. Consequently, 128 patients with non-DMS were assigned to group A, 84 patients with to 2– 3 presentations (without falls) were assigned to group B, and 50 patients with to 4– 5 presentations (without falls) were assigned to group C. Demographic data, diabetes-related complications, and history of falls in the past year were compared to identify risk factors for developing DMS in elderly T2DM patients. Results: It showed that 50.4% of the elderly T2DM patients developed DMS, and 25.2% of them had at least one episode of falling. The average age of the patients and the occurrence of diabetic nephropathy were higher, while diastolic blood pressure and 25-(OH) vitamin D serum calcium and albumin levels were lower in group C than in group A and B(p < 0.05). The occurrence of falls was lower in group A than in the other groups (p = 0.001). Conclusion: Aging, 25 (OH) vitamin D deficiency, and accidental fall history are associated with an increased risk of DMS in elderly patients with T2DM.
- Open Access
- 6 October 2021
- Published by Veritas Publications LTD in European Journal of Environment and Public Health
- Vol. 6 (1) , em0089
Pediatrics Hospital Care in China Before and After Policy Change: A Case Study
Worldwide, healthcare policy change ranks among the top three issues in the public’s consciousness. This study introduces a case study of pediatric hospitalizations at one hospital in Northern China. It seeks to assess whether pediatric hospitalization access, costs, and costs structures favorably changed after selected health policy reforms were implemented in China. A census of all hospital pediatric discharge data from 2015 to 2018 were collected from a general public tertiary hospital in Northern China. Using generalized linear regression, changes in charges for length of stay, daily charges, total charges per discharge, and drug charges and medical service fees as a percent of total charges were analyzed as a function of two independent variables - policy changes regarding the merger of two health insurance programs, and the zero-markup drug pricing policy. These variables were included as dummy variables for the pre-and-post change periods. The covariates used included patient age, sex, and the year. After the policy implementation, significant decreases (P<.01) were found in the length of the hospital stay (-0.49 days) and drug and medical charges (-7.63%) as a percent of total charges. A significant decrease also occurred (P<.01) in the number and percent of pediatric patients served who were self-pay after the merger of the NCMS insurance plan into the URBMI. Drug costs as a proportion of total costs also decreased significantly (P<.01). Thus, the findings revealed that the zero-markup drug pricing policy was associated with a significant decrease (P<.01) in the mean percentage markup for drug charges (P<.01). Accordingly, both health policy changes were associated with positive effects on pediatric healthcare expenditures, and access. This research suggests that as these two policies are fully implemented at public tertiary hospitals throughout China, pediatric hospital care may become even more accessible and drugs less costly.
- 6 October 2021
- Published by Veritas Publications LTD in European Journal of Environment and Public Health
- Vol. 6 (1) , em0089
Open AccessPediatrics Hospital Care in China Before and After Policy Change: A Case Study
Worldwide, healthcare policy change ranks among the top three issues in the public’s consciousness. This study introduces a case study of pediatric hospitalizations at one hospital in Northern China. It seeks to assess whether pediatric hospitalization access, costs, and costs structures favorably changed after selected health policy reforms were implemented in China. A census of all hospital pediatric discharge data from 2015 to 2018 were collected from a general public tertiary hospital in Northern China. Using generalized linear regression, changes in charges for length of stay, daily charges, total charges per discharge, and drug charges and medical service fees as a percent of total charges were analyzed as a function of two independent variables - policy changes regarding the merger of two health insurance programs, and the zero-markup drug pricing policy. These variables were included as dummy variables for the pre-and-post change periods. The covariates used included patient age, sex, and the year. After the policy implementation, significant decreases (P<.01) were found in the length of the hospital stay (-0.49 days) and drug and medical charges (-7.63%) as a percent of total charges. A significant decrease also occurred (P<.01) in the number and percent of pediatric patients served who were self-pay after the merger of the NCMS insurance plan into the URBMI. Drug costs as a proportion of total costs also decreased significantly (P<.01). Thus, the findings revealed that the zero-markup drug pricing policy was associated with a significant decrease (P<.01) in the mean percentage markup for drug charges (P<.01). Accordingly, both health policy changes were associated with positive effects on pediatric healthcare expenditures, and access. This research suggests that as these two policies are fully implemented at public tertiary hospitals throughout China, pediatric hospital care may become even more accessible and drugs less costly.
- Open Access
- 23 September 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (19) , 10004
Inpatient Palliative Care Is Less Utilized in Rare, Fatal Extrahepatic Cholangiocarcinoma: A Ten-Year National Perspective
Background—Extrahepatic cholangiocarcinoma (ECC) is a rare, morbid, fatal cancer with distressing symptoms. Maintaining a high quality of life while reducing hospital charges and length of stay (LOS) for the end-of-life period remains a major challenge for the healthcare system. Palliative care utilization has been shown to address these challenges; moreover, its use has increased in recent years among cancer patients. However, the utilization of palliative care in rare cancers, such as ECC, has not yet been explored. Objectives—To investigate palliative care utilization among ECC patients admitted to US hospitals between 2007 and 2016 and its association with patient demographics, clinical characteristics, hospital charges, and LOS. Methods—De-identified patient data of each hospitalization were retrieved from the National Inpatient Sample (NIS) database. Codes V66.7 (ICD-9-CM) or Z51.5 (ICD-10-CM) were used to find palliative care utilization. Multivariate adjusted logistic regression analyses were conducted to assess factors associated with palliative care use, LOS, hospital charges, and in-hospital death. Results—Of 4426 hospitalizations, only 6.7% received palliative care services. Palliative care utilization did not significantly increase over time (p = 0.06); it reduced hospital charges by USD 25,937 (p < 0.0001) and LOS by 1.3 days (p = 0.0004) per hospitalization. Palliative care was positively associated with female gender, severe disease, and age group ≥80 (p ≤ 0.05). The average LOS was 8.5 days for each admission. Conclusions—Hospital admissions with palliative care utilization had lower hospital charges and LOS in ECC. However, ECC patients received less palliative care compared with more common cancers sharing similar symptoms (e.g., pancreatic cancer). ECC patients also had longer LOS compared with the national average. Further research is warranted to develop interventions to increase palliative care utilization among ECC hospital patients.
- 23 September 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (19) , 10004
Open AccessInpatient Palliative Care Is Less Utilized in Rare, Fatal Extrahepatic Cholangiocarcinoma: A Ten-Year National Perspective
Background—Extrahepatic cholangiocarcinoma (ECC) is a rare, morbid, fatal cancer with distressing symptoms. Maintaining a high quality of life while reducing hospital charges and length of stay (LOS) for the end-of-life period remains a major challenge for the healthcare system. Palliative care utilization has been shown to address these challenges; moreover, its use has increased in recent years among cancer patients. However, the utilization of palliative care in rare cancers, such as ECC, has not yet been explored. Objectives—To investigate palliative care utilization among ECC patients admitted to US hospitals between 2007 and 2016 and its association with patient demographics, clinical characteristics, hospital charges, and LOS. Methods—De-identified patient data of each hospitalization were retrieved from the National Inpatient Sample (NIS) database. Codes V66.7 (ICD-9-CM) or Z51.5 (ICD-10-CM) were used to find palliative care utilization. Multivariate adjusted logistic regression analyses were conducted to assess factors associated with palliative care use, LOS, hospital charges, and in-hospital death. Results—Of 4426 hospitalizations, only 6.7% received palliative care services. Palliative care utilization did not significantly increase over time (p = 0.06); it reduced hospital charges by USD 25,937 (p < 0.0001) and LOS by 1.3 days (p = 0.0004) per hospitalization. Palliative care was positively associated with female gender, severe disease, and age group ≥80 (p ≤ 0.05). The average LOS was 8.5 days for each admission. Conclusions—Hospital admissions with palliative care utilization had lower hospital charges and LOS in ECC. However, ECC patients received less palliative care compared with more common cancers sharing similar symptoms (e.g., pancreatic cancer). ECC patients also had longer LOS compared with the national average. Further research is warranted to develop interventions to increase palliative care utilization among ECC hospital patients.
- 19 September 2011
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 6 (4) , e340-e346
Value of dual-energy X-ray absorptiometry derived parameters vs anthropometric obesity indices in the assessment of early atherosclerosis in abdominally obese men
- 19 September 2011
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 6 (4) , e340-e346
Value of dual-energy X-ray absorptiometry derived parameters vs anthropometric obesity indices in the assessment of early atherosclerosis in abdominally obese men